Atropine Sulfate Injection — FDA Drug Shortage

Current — Medefil, Inc.

The FDA lists a drug shortage record for Atropine Sulfate Injection (injection) from Medefil, Inc. with status Current. The shortage was first posted on 01/01/2012.

Shortage Details

Status
Current
Company
Medefil, Inc.
Package NDC
64253-400-91
Dosage Form
Injection
Presentation
Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 64253-400-91)
Initial Posting
01/01/2012
Revised Date